about
Autism-associated gene Dlgap2 mutant mice demonstrate exacerbated aggressive behaviors and orbitofrontal cortex deficitsMossy fiber sprouting in pilocarpine-induced status epilepticus rat hippocampus: a correlative study of diffusion spectrum imaging and histology.Collaboration of fibronectin matrix and neurotrophin in regulating spontaneous transmitter release at developing neuromuscular synapses in Xenopus cell cultures.Molecular and clinical analyses of 84 patients with tuberous sclerosis complex.Levetiracetam inhibits glutamate transmission through presynaptic P/Q-type calcium channels on the granule cells of the dentate gyrus.Geographic variation in the age- and gender-specific prevalence and incidence of epilepsy: analysis of Taiwanese National Health Insurance-based data.Structural basis of binding and inhibition of novel tarantula toxins in mammalian voltage-dependent potassium channels.Lovastatin modulates glycogen synthase kinase-3β pathway and inhibits mossy fiber sprouting after pilocarpine-induced status epilepticus.Regulation of ROMK1 channel by protein kinase A via a phosphatidylinositol 4,5-bisphosphate-dependent mechanismGabapentin activates ROMK1 channels by a protein kinase A (PKA)-dependent mechanism.SDF-1/CXCR4 Signaling Maintains Stemness Signature in Mouse Neural Stem/Progenitor Cells.YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway.Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan.Association of polymorphisms in NR1I2 and ABCB1 genes with epilepsy treatment responses.Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser.Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.Prevalence and risk factors of somatic and autonomic neuropathy in prediabetic and diabetic patients.Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study.Attenuation of paraquat-induced dopaminergic toxicity on the substantia nigra by (-)-deprenyl in vivo.Two-stage community-based screening model for estimating prevalence of diabetic polyneuropathy (KCIS no. 6).Risk factors associated with infantile spasms: a hospital-based case-control study in Taiwan.Interaction between anticonvulsants and human placental carnitine transporter.Gene-wide tagging study of the effects of common genetic polymorphisms in the α subunits of the GABA(A) receptor on epilepsy treatment response.Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms.Functional and structural characterization of PKA-mediated pHi gating of ROMK1 channels.Sibutramine-induced recurrent seizures.Paraquat inhibits postsynaptic AMPA receptors on dopaminergic neurons in the substantia nigra pars compacta.Effects of sodium azide, barium ion, d-amphetamine and procaine on inward rectifying potassium channel 6.2 expressed in Xenopus oocytes.d-Amphetamine inhibits inwardly rectifying potassium channels in Xenopus oocytes expression system.PKA-mediated phosphorylation is a novel mechanism for levetiracetam, an antiepileptic drug, activating ROMK1 channels.Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response.Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs.Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus.Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy.A possible molecular mechanism of hanatoxin binding-modified gating in voltage-gated K+-channels.GABAergic tonic inhibition is regulated by developmental age and epilepsy in the dentate gyrus.Theory of mind in patients with temporal lobe epilepsy.Painful neuropathy due to skin denervation after metronidazole-induced neurotoxicity.Impaired gist memory in patients with temporal lobe epilepsy and hippocampal sclerosis.Treatment of advanced Parkinson's disease by subthalamotomy: one-year results.
P50
Q28391134-B685A524-123E-4904-A7C9-139E51114DA9Q31153936-AA4EEF23-8AAA-461C-9C6F-926932470858Q32025360-2794DC03-9D10-455B-A568-E109EBE37086Q33257900-3DB0CB35-BA0D-4B4E-BDFB-ED88527264EEQ33569536-4BF19A83-F8EE-4032-8FE0-D711E88B219CQ34086019-EB4F7F14-E48C-4B9F-811D-3948F252B4A5Q34270799-04521D56-FCCB-4DE9-9A46-16A3609319BCQ34325797-11E79780-1F11-4AC3-8035-1B6033252053Q36372211-A4F7C4CC-F390-463A-B7DC-4E5452345681Q36735864-095DA019-D776-4318-BFFA-59B2FD7E92DCQ37734372-770F765D-9845-4F6E-947E-712AF6188340Q39672848-1371FCE6-EC9A-45D8-8B97-44847FDDCDA4Q39906423-FC723A00-CD43-4576-9354-022B98C4C1B5Q40165900-3D714406-AF55-4C90-81A7-577B19FAEDAAQ42942105-60810AD5-919D-46A3-9B02-98EAE21B0EB3Q43061447-0D2108AB-8E5E-4E09-A641-A654A1EE736CQ43249014-B0138C27-989A-4CDB-A464-DF2474F92D40Q43270753-0E4FFB41-1E91-48E9-91F4-A5F5C0DDDEEEQ43550940-0A992EB1-2393-4E05-80A7-F862989A2425Q44174028-26868364-40D1-4EF0-9E53-4E095B311BEEQ44438263-DFE6EAE9-A2C9-45FB-B8C6-FCF4CF17F3E7Q44792007-64715CE9-ADC7-459C-A872-30899A303B62Q44966357-081B7AFC-CFC2-465C-8557-060FB6A3E53FQ45073052-AB821A82-5533-40B7-9D10-045F92E1934DQ45730451-B0C76E82-704D-480C-8DB7-B91EB58836BFQ46019329-6EB8C07C-B42B-48C2-B211-85F632CFD462Q46399221-3AA1EAA7-5F42-4979-9590-163DB3DC5421Q46446960-229AF307-C0CB-4237-A616-741BD1DE633EQ46525316-25B64E08-CFAF-4482-8D5B-BE3D100F5409Q46545287-202FC1BF-193E-46B6-88F9-5EFBE57B3D5AQ46590281-50734698-0155-439D-A8AC-E17D9C836E11Q46647764-B73DA328-2FB7-4ED5-A109-CA8DB10D9F9CQ46773153-4FAA3CC0-E0D3-4D70-A1DB-FEDFDE02F480Q46836748-50E62EF5-BB77-4758-AEA0-1A6B5F7115F3Q47254393-7B49C1C2-3A31-4107-8DEF-58F9CC4E4B59Q48007753-F0E098A2-7C37-401D-A01A-59F4E0BBF68DQ48140819-F84F3234-588F-49FC-A922-BC041293540DQ48164556-86C7CBC1-334A-4C17-9C1E-6EB9D96B236FQ48319884-647B71F0-3F1D-403A-ACB8-0A22C4AB81F3Q48322019-E0D494B4-EED9-4271-91A8-E6F0D61BBB27
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Horng-huei Liou
@ast
Horng-huei Liou
@en
Horng-huei Liou
@es
Horng-huei Liou
@nl
Horng-huei Liou
@sl
type
label
Horng-huei Liou
@ast
Horng-huei Liou
@en
Horng-huei Liou
@es
Horng-huei Liou
@nl
Horng-huei Liou
@sl
altLabel
劉宏輝
@en
prefLabel
Horng-huei Liou
@ast
Horng-huei Liou
@en
Horng-huei Liou
@es
Horng-huei Liou
@nl
Horng-huei Liou
@sl
P106
P1153
7102330017
P31
P496
0000-0001-6537-5346